NRX Pharmaceuticals (B1Q.F) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.84
-0.5
-0.16
0.18

Details

Expected EPS
0.1797453024
Actual EPS
-0.0344076
Surprise EPS
-0.21
Surprise Percent
+119.14%

Description

NRX Pharmaceuticals (B1Q.F) has reported earnings of -0.0344076 per share for Q2 2026.

0 Comments

Share your thoughts